Annual CFI
$76.05 M
+$167.44 M+183.21%
31 December 2023
Summary:
Kezar Life Sciences annual cash flow from investing activities is currently $76.05 million, with the most recent change of +$167.44 million (+183.21%) on 31 December 2023. During the last 3 years, it has risen by +$132.54 million (+234.60%). KZR annual CFI is now at all-time high.KZR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$24.06 M
+$11.84 M+96.95%
30 September 2024
Summary:
Kezar Life Sciences quarterly cash flow from investing activities is currently $24.06 million, with the most recent change of +$11.84 million (+96.95%) on 30 September 2024. Over the past year, it has increased by +$5.49 million (+29.54%). KZR quarterly CFI is now -37.48% below its all-time high of $38.48 million, reached on 30 September 2021.KZR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$84.56 M
+$5.49 M+6.94%
30 September 2024
Summary:
Kezar Life Sciences TTM cash flow from investing activities is currently $84.56 million, with the most recent change of +$5.49 million (+6.94%) on 30 September 2024. Over the past year, it has increased by +$45.05 million (+114.04%). KZR TTM CFI is now at all-time high.KZR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KZR Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +183.2% | +29.5% | +114.0% |
| 3 y3 years | +234.6% | -37.5% | +18.5% |
| 5 y5 years | +190.6% | +54.0% | +858.2% |
KZR Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +183.2% | -37.5% | +129.2% | at high | +151.2% |
| 5 y | 5 years | at high | +183.2% | -37.5% | +129.2% | at high | +151.2% |
| alltime | all time | at high | +183.2% | -37.5% | +129.2% | at high | +151.2% |
Kezar Life Sciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $24.06 M(+97.0%) | $84.56 M(+6.9%) |
| June 2024 | - | $12.22 M(-40.1%) | $79.08 M(-1.2%) |
| Mar 2024 | - | $20.41 M(-26.8%) | $80.06 M(+5.3%) |
| Dec 2023 | $76.05 M(-183.2%) | $27.88 M(+50.1%) | $76.05 M(+92.5%) |
| Sept 2023 | - | $18.57 M(+40.7%) | $39.51 M(-1146.5%) |
| June 2023 | - | $13.20 M(-19.4%) | -$3.77 M(-75.6%) |
| Mar 2023 | - | $16.39 M(-289.3%) | -$15.47 M(-83.1%) |
| Dec 2022 | -$91.39 M(+221.3%) | -$8.66 M(-64.9%) | -$91.39 M(-44.7%) |
| Sept 2022 | - | -$24.71 M(-1736.3%) | -$165.22 M(+61.9%) |
| June 2022 | - | $1.51 M(-102.5%) | -$102.03 M(+16.9%) |
| Mar 2022 | - | -$59.53 M(-27.8%) | -$87.29 M(+206.9%) |
| Dec 2021 | -$28.44 M(-49.7%) | -$82.49 M(-314.4%) | -$28.44 M(-139.9%) |
| Sept 2021 | - | $38.48 M(+136.8%) | $71.36 M(+100.1%) |
| June 2021 | - | $16.25 M(-2465.4%) | $35.67 M(-299.8%) |
| Mar 2021 | - | -$687.00 K(-104.0%) | -$17.86 M(-68.4%) |
| Dec 2020 | -$56.50 M | $17.32 M(+520.7%) | -$56.50 M(-21.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $2.79 M(-107.5%) | -$72.14 M(+21.6%) |
| June 2020 | - | -$37.28 M(-5.2%) | -$59.30 M(+198.2%) |
| Mar 2020 | - | -$39.33 M(-2443.9%) | -$19.89 M(-197.4%) |
| Dec 2019 | $20.42 M(-124.3%) | $1.68 M(-89.3%) | $20.42 M(+131.4%) |
| Sept 2019 | - | $15.62 M(+629.4%) | $8.82 M(-113.9%) |
| June 2019 | - | $2.14 M(+119.5%) | -$63.47 M(-23.3%) |
| Mar 2019 | - | $976.00 K(-109.8%) | -$82.73 M(-1.4%) |
| Dec 2018 | -$83.90 M(>+9900.0%) | -$9.92 M(-82.5%) | -$83.90 M(+13.3%) |
| Sept 2018 | - | -$56.67 M(+231.0%) | -$74.05 M(+318.2%) |
| June 2018 | - | -$17.12 M(+8680.5%) | -$17.71 M(+2931.8%) |
| Mar 2018 | - | -$195.00 K(+209.5%) | -$584.00 K(+50.1%) |
| Dec 2017 | -$389.00 K(+194.7%) | -$63.00 K(-80.7%) | -$389.00 K(+19.3%) |
| Sept 2017 | - | -$326.00 K(<-9900.0%) | -$326.00 K(<-9900.0%) |
| June 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2017 | - | $0.00 | $0.00 |
| Dec 2016 | -$132.00 K | - | - |
FAQ
- What is Kezar Life Sciences annual cash flow from investing activities?
- What is the all time high annual CFI for Kezar Life Sciences?
- What is Kezar Life Sciences annual CFI year-on-year change?
- What is Kezar Life Sciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Kezar Life Sciences?
- What is Kezar Life Sciences quarterly CFI year-on-year change?
- What is Kezar Life Sciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Kezar Life Sciences?
- What is Kezar Life Sciences TTM CFI year-on-year change?
What is Kezar Life Sciences annual cash flow from investing activities?
The current annual CFI of KZR is $76.05 M
What is the all time high annual CFI for Kezar Life Sciences?
Kezar Life Sciences all-time high annual cash flow from investing activities is $76.05 M
What is Kezar Life Sciences annual CFI year-on-year change?
Over the past year, KZR annual cash flow from investing activities has changed by +$167.44 M (+183.21%)
What is Kezar Life Sciences quarterly cash flow from investing activities?
The current quarterly CFI of KZR is $24.06 M
What is the all time high quarterly CFI for Kezar Life Sciences?
Kezar Life Sciences all-time high quarterly cash flow from investing activities is $38.48 M
What is Kezar Life Sciences quarterly CFI year-on-year change?
Over the past year, KZR quarterly cash flow from investing activities has changed by +$5.49 M (+29.54%)
What is Kezar Life Sciences TTM cash flow from investing activities?
The current TTM CFI of KZR is $84.56 M
What is the all time high TTM CFI for Kezar Life Sciences?
Kezar Life Sciences all-time high TTM cash flow from investing activities is $84.56 M
What is Kezar Life Sciences TTM CFI year-on-year change?
Over the past year, KZR TTM cash flow from investing activities has changed by +$45.05 M (+114.04%)